Institut Curie (Curie Cancer Carnot Institute) announces the launch of biotechnology company Honing Biosciences, a technology platform that develops solutions to optimize the efficiency and safety of cell therapies in cancer and chronic diseases.
Wednesday 7 November 2018 officially launches the European Plate Observing System (EPOS) for the pooling of data and services for the study of our planet. BRGM Carnot Institute is part of this initiative.
Organized by Cetim Carnot Institute, the 8th Fatigue Design conference held in 2019 aims to present the most innovative approaches and scientific progress in design methodologies, tools, and equipment’s life extension, focusing on industrial applications.
For this edition, a new focus is made on the relation between additive manufacturing and fatigue.
Place : Senlis in France.
Date : From November 20, 2019 to November 21, 2019
Philips and Institut Curie (Curie Cancer Carnot Institute) have decided to invest more than 250 000 euros each in a partnership linked to the clinical use of the nuclear medicine PET scan Vereos, the first and only entirely digital PET/CT currently available on the market. Such a system can offer improved spatial resolution, significant gain in sensitivity and a better precision compared to standard analog systems.
Leti Carnot Institute organize Memory Workshop on eNVM, July 2nd 2018 - Grenoble - France.
This one-day workshop will explore short-term and long-term memory solutions. Industrials and experts will share their views, discuss start-up creation and introduce disruptive concepts that will soon penetrate the market. To expand our horizons, world-class academics will also provide their views on non-conventional applications.
Curie Cancer Carnot Institute names Intel lead partner to implement high performance computing and artificial intelligence in accelerating genome sequencing and interpretation for oncology
Curie Cancer Carnot Institute and Intel initiate a pioneering collaboration to develop, use and implement innovative Bioinformatics tools, pipelines and techniques to improve the use of molecular profiling across both research and clinical oncology settings.
Curie Cancer Carnot Institute and Freenome announce a strategic collaboration in cell-free DNA analysis using machine learning technology
Curie Cancer Carnot Institute and Freenome announce a strategic collaboration to evaluate Freenome’s artificial intelligence (AI) genomics platform as a novel tool to predict patient response to immuno-oncology therapies by observing changes in circulating cell-free biomarkers.
Leti Innovation Days 2018 on July 4-5th will include a series of keynotes and panel sessions from industry leaders and academics. Along the conference, a special exhibition will be open in the afternoons, and will gather microelectronics industrials and successful start-ups.
This year, there will be 7 satellite workshops on various technical fields :
- Design for 3D
- Silicon photonics
- 5 G
- MEMS & sensors
The CALYM Carnot Institute and the Institut Roche, Partners to Accelerate Together Research against Lymphoma!
At the end of December 2017, a framework contract was signed between CALYM and the Institut Roche to define the terms of a joint call for projects for the development of preclinical and translational research partnerships in onco-hematology.
The Carnot Insitute CALYM obtained the renewal of its ISO 9001 certification for the management and monitoring of its research activities and the coordination of its CeVi collection of lymphoma viable cells. Particularity of this year, the changeover to the 2015 version.
Paris, September 25th, 2017 - The Institut Curie (Curie Cancer Carnot Institute) has adopted an ambitious strategy for technology transfer and partnerships with innovative companies. This new dynamic, initiated within the framework of the 2015-2020 MC21 strategic plan, aims at positioning the Institut Curie a reference for technology transfer in oncology. Faithful to the model conceived by Marie Curie in 1909, this new breath will strengthen the interactions between research and care, catalyzing the transformation of research findings into medical applications for maximum patient benefit.